Skip to main content
. 2016 Aug 12;8(41):69408–69421. doi: 10.18632/oncotarget.11242

Table 1. Serum levels of top-ranked proteins differentiating between A) MGUS vs MM, B) healthy controls vs MGUS, C) healthy controls vs MM, D) MM vs MM-ASCT and E) healthy controls vs MM-ASCT.

Analyte Mean Linear ddCq (95% CI) FC P Pcorr
A MGUS MM
ADM 46.9 (28.4-65.4) 191 (121-262) 2.80 4.0 × 10-6 3.5 × 10-4
TRAP 28.9 (22.3-35.6) 85.1 (42.8-127) 2.33 3.7 × 10-5 1.6 × 10-3
GDF15 12.6 (9.19-16.0) 53.3 (22.5-84.1) 2.72 1.1 × 10-4 3.0 × 10-3
suPAR 295 (251-338) 486 (368-603) 1.60 2.7 × 10-4 5.9 × 10-3
REG4 5.96 (5.46-6.46) 9.58 (6.78-12.4) 1.30 1.2 × 10-3 .021
TGFB1 42.9 (39.0-46.8) 85.5 (43.7-127) 1.41 1.9 × 10-3 .023
sMICA 15.4 (9.98-20.8) 39.4 (26.8-52.1) 2.29 2.1 × 10-3 .023
IL1RA 9.22 (7.23-11.2) 60.0 (0-145) 1.71 2.6 × 10-3 .023
HE4 18.4 (15.6-21.3) 89.8 (0-190) 1.72 3.0 × 10-3 .023
sHGFR 259 (240-278) 580 (199-960) 1.26 3.0 × 10-3 .023
sVEGFA 892 (728-1056) 1628 (1082-2173) 1.47 3.0 × 10-3 .023
B healthy controls MGUS
Midkine 30.3 (25.8-34.8) 75.0 (60.8-89.3) 2.24 8.2 × 10-6 7.0 × 10-4
THPO 13.1 (11.7-14.6) 24.2 (18.8-29.6) 1.79 9.8 × 10-5 4.2 × 10-3
sTNFRSF4 4.12 (3.29-4.94) 7.39 (6.05-8.72) 1.54 1.6 × 10-4 4.4 × 10-3
sHER4 174 (163-184) 270 (228-311) 1.45 2.4 × 10-4 4.5 × 10-3
IFNγ 1.58 (1.52-1.64) 2.17 (1.95-2.39) 1.31 3.1 × 10-4 4.5 × 10-3
TGFB1 61.9 (54.2-69.5) 42.9 (39.0-46.8) .71 3.7 × 10-4 4.5 × 10-3
sPECAM1 15.6 (12.6-18.7) 28.7 (23.3-34.1) 1.56 3.7 × 10-4 4.5 × 10-3
sIL17RB 5.56 (3.84-7.28) 10.9 (9.09-12.7) 1.81 1.1 × 10-3 .010
KLK6 28.6 (24.5-32.8) 44.0 (37.9-50.2) 1.29 1.1 × 10-3 .010
suPAR 425 (373-476) 295 (251-338) .69 2.0 × 10-3 .017
C healthy controls MM
PGF 59.2 (52.5-66.0) 137 (97.2-177) 1.72 1.6 × 10-5 1.4 × 10-3
GDF15 8.34 (6.14-10.5) 53.3 (22.5-84.1) 3.69 9.8 × 10-5 4.2 × 10-3
HE4 12.9 (10.4-15.5) 89.8 (0-190) 2.56 1.6 × 10-4 4.4 × 10-3
sTNFR2 9.52 (7.93-11.1) 17.9 (14.3-21.6) 1.88 2.4 × 10-4 5.3 × 10-3
CSF1 100 (94.4-106) 195 (115-275) 1.64 3.7 × 10-4 5.3 × 10-3
Midkine 30.3 (25.8-34.8) 158 (82.9-232) 3.42 3.7 × 10-4 5.3 × 10-3
sPECAM1 15.6 (12.6-18.7) 69.6 (17.4-122) 2.38 7.7 × 10-4 9.3 × 10-3
CCL19 463 (317-609) 929 (733-1125) 1.76 1.1 × 10-3 9.3 × 10-3
sVEGFA 765 (700-830) 1628 (1082-2173) 1.57 1.1 × 10-3 9.3 × 10-3
IFNγ 1.58 (1.52-1.64) 5.17 (0-11.1) 1.47 1.1 × 10-3 9.3 × 10-3
D MM MM-ASCT
REG4 9.58 (6.78-12.4) 7.01 (4.50-9.51) .74 3.1 × 10-5 2.6 × 10-3
sBAFF 18.4 (10.5-26.3) 62.3 (51.8-72.9) 4.38 1.5 × 10-4 6.1 × 10-3
sPECAM1 69.6 (17.4-122) 17.3 (13.1-21.6) .41 2.1 × 10-4 6.1 × 10-3
sIL6R 174 (99.3-249) 81.6 (64.6-98.6) .55 5.8 × 10-4 .012
sPDGFB 544 (299-789) 274 (222-327) .56 7.6 × 10-4 .013
Midkine 158 (82.9-232) 54.5 (42.7-66.3) .54 1.0 × 10-3 .014
sHGF 47.1 (32.5-61.6) 26.9 (20.7-33.1) .63 1.3 × 10-3 .014
TGFB1 85.5 (43.7-127) 41.6 (34.9-48.3) .72 1.3 × 10-3 .014
sAREG 19.0 (5.32-32.8) 7.52 (6.17-8.87) .67 1.7 × 10-3 .016
sMICA 39.4 (26.8-52.1) 22.5 (15.8-29.2) .59 2.1 × 10-3 .018
E healthy controls MM-ASCT
sBAFF 14.1 (12.9-15.3) 62.3 (51.8-72.9) 4.32 8.2 × 10-6 7.0 × 10-4
CSF1 100 (94.4-106) 152 (131-173) 1.44 2.4 × 10-4 6.0 × 10-3
sTGFA 24.4 (19.6-29.2) 11.9 (9.03-14.8) .36 2.4 × 10-4 6.0 × 10-3
TRAP 32.2 (25.0-39.4) 71.2 (42.5-100.0) 1.82 3.7 × 10-4 6.0 × 10-3
CXCL10 130 (61.2-199) 667 (323-1011) 4.05 5.4 × 10-4 6.0 × 10-3
sTNFR2 9.52 (7.93-11.1) 21.2 (17.6-24.9) 2.45 5.4 × 10-4 6.0 × 10-3
sTNFRSF4 4.12 (3.29-4.94) 10.9 (7.21-14.6) 2.22 5.4 × 10-4 6.0 × 10-3
Flt3L 254 (225-284) 522 (411-633) 2.07 7.7 × 10-4 6.0 × 10-3
GDF15 8.34 (6.14-10.5) 22.7 (16.5-28.8) 2.50 7.7 × 10-4 6.0 × 10-3
HE4 12.9 (10.4-15.5) 43.6 (3.61-83.5) 1.88 7.7 × 10-4 6.0 × 10-3
THPO 13.1 (11.7-14.6) 28.5 (21.7-35.3) 2.23 7.7 × 10-4 6.0 × 10-3

FC (Fold Change) between group medians of linear ddCq

*Pcorr value corrected for multiple comparisons (Benjamini-Hochberg correction)